{
  "title": "Vincenti ITN023ST:  Belatacept to Prevent Organ Rejection in Kidney Transplant Patients",
  "identifier": {
    "identifier": "http://www.immport.org/immport-open/public/study/study/displayStudyDetail/SDY674",
    "identifierSource": "http://www.immport.org"
  },
  "producedBy": {  "name": "Vincenti ITN023ST:  Belatacept to Prevent Organ Rejection in Kidney Transplant Patients",
  "performedBy": [
    {
      "firstName": "Flavio",
      "lastName": "Vincenti",
      "email": "flavio.Vincenti@ucsfmedctr.org",
      "affiliations": [
          {
             "name": "University of California, San Francisco"
          }
      ],
      "roles": [
          {
             "value": "Principal Investigator"
          }
      ]
    },
    {
      "firstName": "Christian",
      "lastName": "Larsen",
      "email": "clarsen@emory.edu",
      "affiliations": [
          {
             "name": "Emory University"
          }
      ],
      "roles": [
          {
             "value": "Co-Principal Investigator"
          }
      ]
    }
  ],
  "studyGroups": [
        {
          "name": "Belatacept treatment",
          "size": 5
        },
        {
          "name": "Donor",
          "size": 5
        }
  ],
  
  "selectionCriteria": [
        {
          "category": "Inclusion",
          "values": [
              "Receiving first renal (e.g., kidney) transplant"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Transplant is from a non-HLA-identical living donor"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Willing to use acceptable forms of contraception"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Positive for anti-human globulin (AHG) or T-cell cross-match with the donor"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Receiving multiple-organ transplant"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "History of cancer within the 5 years prior to study entry. Patients who have certain nonmelanoma skin cancers are not excluded"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Human immunodeficiency virus (HIV) infected"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Hepatitis B (HBV) or C (HCV) virus infected"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Other active infections"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Active tuberculosis (TB) infection within the 3 years prior to study entry"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Pregnancy or breastfeeding"
          ]
        }
  ],
  
  "types": [
      {
          "value": "Interventional"
      }
  ]
  },
  "creators": [
    {
      "firstName": "Flavio",
      "lastName": "Vincenti",
      "email": "flavio.Vincenti@ucsfmedctr.org",
      "affiliations": [
          {
             "name": "University of California, San Francisco"
          }
      ],
      "roles": [
          {
             "value": "Principal Investigator"
          }
      ]
    },
    {
      "name": "Immune Tolerance Network",
      "extraProperties": [
        {
          "category": "Catgory",
          "values": [
            {
              "value": "DAIT"
            }
          ]
        },
        {
          "category": "External Id",
          "values": [
            {
              "value": "N/A1"
            }
          ]
        },
        {
          "category": "Description",
          "values": [
            {
              "value": "Immune Tolerance Network"
            }
          ]
        }
      ]
    }
  ],
  
  "primaryPublications": [
    {
      "identifier":
        {
          "identifier": "16120857",
          "identifierSource": "pubmed"
        },
      "authorsList": "Vincenti F(1), Larsen C, Durrbach A, Wekerle T, Nashan B, Blancho G, Lang P, Grinyo J, Halloran PF, Solez K, Hagerty D, Levy E, Zhou W, Natarajan K, Charpentier B; Belatacept Study Group.",
      "title": "Costimulation blockade with belatacept in renal transplantation.",
      "publicationVenue": "N Engl J Med.",
      "dates": [
        {
          "date": "2005",
          "type": { "value": "publication year" }
        }
      ]
    }
  ],
  "types": [
      {
        "value": "Clinical Trial"
      },
      {
        "value": "Interventional"
      },
      {
        "value": "Transplantation"
      }
  ],
  "dates": [
      {
          "date": "2006-12-01",
          "type": {
              "value": "actual_start_date"
          }
      },
      {
          "date": "2016-02-05",
          "type": {
              "value": "final_public_release_date"
          }
      }
  ],
  "availability": "Available for download after registration with ImmPort",
  "refinement": "Curated",
  "dimensions": [{
        "name": {
            "value": "Urinalysis"
        }
      },{
        "name": {
            "value": "Blood Cell Count with Differential"
        }
      },{
        "name": {
            "value": "Comprehensive Metabolic Panel"
        }
      },{
        "name": {
            "value": "Overall Outcome"
        }
      }
      
  ],
  
  "distributions": [
      {
          "identifier": {
              "identifier": "SDY674",
              "identifierSource": "ImmPort"
          },
          "title": "Vincenti ITN023ST:  Belatacept to Prevent Organ Rejection in Kidney Transplant Patients",
          "access": {
              "landingPage": "http://www.immport.org",
              "accessURL": "http://www.immport.org/immport-open/public/study/study/displayStudyDetail/SDY674",
              "types": [
                  {
                      "value": "Download tab separated files"
                  },
                  {
                      "value": "Download MySQL files and schema"
                  }
              ],
              "authorizations": [
                {
                    "value": "Registraton with ImmPort required"
                }
              ]
          },
          "storedIn": {
              "name": "ImmPort",
              "types": [
                {
                  "value": "primary repository"
                }
              ]
         },
         "licenses": [
           {
             "name": "ImmPort User Agreement",
             "version": "1.0",
             "extraProperties": [
               {
                 "category": "Link to User Agreement",
                 "values": [
                   {
                     "value": "http://www.immport.org/agreement"
                   }
                 ]
               }
             ]
           }
         ]
      }
  ],
  "acknowledges": [
    {
      "identifier": {
        "identifier": ""
      },
      "name": "Immune Tolerance Network",
      "extraProperties": [
        {
          "category": "Link",
          "values": [
            {
              "value": "https://www.fpds.gov/ezsearch/search.do?s=FPDS&q=%22IT+strategy%22+OR+%22enterprise+architecture%22+DEPARTMENT_FULL_NAME%3A%22HEALTH+AND+HUMAN+SERVICES%2C+DEPARTMENT+OF%22+PIID%3A%22HHSD2002011F41972%22+VENDOR_ADDRESS_ZIP_CODE%3A%22221027508%22+GLOBAL_VENDOR_NAME%3A%22GAVER+TECHNOLOGIES++INC.%22+VENDOR_FULL_NAME%3A%22VANGENT%2C+INC.%22+TREASURY_ACCOUNT_SYMBOL%3A%22750885%22+CONTRACTING_OFFICE_NAME%3A%22NIH%2C+NIAID+DEA+OA+OFC+ACQUISITIONS%22+VENDOR_FULL_NAME%3A%22ST.+LOUIS+UNIVERSITY%22+PRODUCT_OR_SERVICE_CODE%3A%22AB93%22+PRINCIPAL_NAICS_CODE%3A%22325414%22+VENDOR_ADDRESS_ZIP_CODE%3A%22277088990%22+PIID%3A%22HHSN266200500019C%22&indexName=awardfull&templateName=1.4.4"
            }
          ]
        }
      ]}
  ],
  "licenses": [
    {
      "name": "ImmPort User Agreement",
      "version": "1.0",
      "extraProperties": [
        {
          "category": "Link to User Agreement",
          "values": [
            {
              "value": "http://www.immport.org/agreement"
            }
          ]
        }
      ]
    }
  ],
  "description": "This study evaluates whether belatacept and a combination of anti-rejection drugs prevents  non-human leukocyte antigen identical renal transplant rejection allowing safe anti-rejection therapy withdrawal one year post-transplant"
}
